Pulse BiosciencesPLSE +3.42%31 Days Inventory is 42.17 as of Mar. 2026, which is 76% below its 10-year median of 177.98. GuruFocus rates PLSE with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Pulse Biosciences ranks better than 95.93% on this metric.
The historical rank and industry rank for Pulse Biosciences's Days Inventory or its related term are showing as below:
PLSE'
s Days Inventory Range Over the Past 10 Years
Min: 38.55 Med: 177.98 Max: 1080.16
Current: 38.55
During the past 12 years, Pulse Biosciences's highest Days Inventory was 1080.16. The lowest was 38.55. And the median was 177.98.
PLSE's Days Inventory is ranked better than 95.93% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.86
vs PLSE: 38.55
Pulse Biosciences's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (42.17).
It might indicate that Pulse Biosciences's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pulse Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.16.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pulse Biosciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.43.
Pulse Biosciences (NAS:PLSE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pulse Biosciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pulse Biosciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pulse Biosciences Days Inventory Related Terms
Pulse Biosciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Pulse Biosciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLSE vs NNNN, STAA, ATRC: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Pulse Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulse Biosciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pulse Biosciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulse Biosciences (PLSE) has a Days Inventory of 42.17 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pulse Biosciences and its competitors. This is 76% below median its historical median of 177.98. Over the past decade, Pulse Biosciences' Days Inventory has ranged from 38.55 to 1,080.16. According to the industry distribution chart, Pulse Biosciences ranks #32 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 4.1%.
Is Pulse Biosciences' Days Inventory too high?
Pulse Biosciences' current Days Inventory of 42.17 is 76% below median its 10-year median of 177.98. Over the past 10 years, this metric has ranged from a low of 38.55 to a high of 1,080.16. The Medical Devices & Instruments industry median Days Inventory is 179.86. Pulse Biosciences' value of 42.17 is 76.6% below this industry median. Based on the distribution chart, Pulse Biosciences ranks #32 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pulse Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' Days Inventory compare to NNNN and STAA?
According to the Medical Devices & Instruments industry distribution chart, Pulse Biosciences ranks #32 out of 786 companies for Days Inventory. This places Pulse Biosciences in the top 4% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.86. Pulse Biosciences' value of 42.17 is 76.6% below this benchmark. Historically, Pulse Biosciences' own Days Inventory has ranged from 38.55 to 1,080.16 over the past decade. While the company's 10-year median is 177.98 vs. the industry median of 179.86, Pulse Biosciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.86, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulse Biosciences's current Days Inventory of 42.17 is 76.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pulse Biosciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulse Biosciences's current Days Inventory is 42.17, which is 76% below median its own 10-year median of 177.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current Days Inventory of 42.17. The current Days Inventory is 42.17, which is 76% below median its 10-year median of 177.98 and 76.6% below the Medical Devices & Instruments industry median of 179.86. Pulse Biosciences' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current Days Inventory is 42.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
31GF Score
Get the complete analysis for PLSE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSE has been successfully added to your 
